Skip to content
Advertisement

FILE - Johnson & Johnson Consumer Health in Flourtown, Pa., Friday, April 28, 2023. A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement to cover allegations that its baby powder containing talc caused ovarian cancer. J&J said that the reorganization plan for the subsidiary that was being announced on Wednesday, May 1, 2024, was significantly different from the previous reorganization that was announced. (AP Photo/Matt Rourke)

FILE - Johnson & Johnson Consumer Health in Flourtown, Pa., Friday, April 28, 2023. A subsidiary of Johnson & Johnson is now proposing paying approximately $6.48 billion over 25 years as part of a settlement to cover allegations that its baby powder containing talc caused ovarian cancer. J&J said that the reorganization plan for the subsidiary that was being announced on Wednesday, May 1, 2024, was significantly different from the previous reorganization that was announced. (AP Photo/Matt Rourke)

Featured Photo Galleries